XML 20 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814
Financial Instruments and Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The financial instruments measured at fair value on a recurring basis at September 30, 2015 were as follows:
 
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
30,903

 
$

 
$

 
$
30,903

Commercial paper
98,984

 

 

 
98,984

Debt securities:
 
 
 
 
 
 
 
U.S. Treasury securities
234,861

 

 

 
234,861

Corporate debt securities

 
5,269

 

 
5,269

Preferred stock

 
11,895

 

 
11,895

Restricted investments:
 
 
 
 
 
 
 
Guaranteed income fund

 
7,156

 

 
7,156

 
$
364,748

 
$
24,320

 
$

 
$
389,068



The financial instruments measured at fair value on a recurring basis at December 31, 2014 were as follows:
 
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
19,971

 
$

 
$

 
$
19,971

Debt securities:
 
 
 
 
 
 
 
U.S. Treasury securities
509,815

 

 

 
509,815

Corporate debt securities

 
100,105

 

 
100,105

Preferred stock

 
26,958

 

 
26,958

Restricted investments:
 
 
 
 
 
 


Guaranteed income fund

 
7,940

 

 
7,940

 
$
529,786

 
$
135,003

 
$

 
$
664,789

Carrying Amount and Fair Value of Financial Instruments
The carrying amount and fair value of the Company’s financial instruments were as follows:
 
September 30, 2015
 
December 31, 2014
 
Carrying 
value
 
Fair value
 
Level
 
Carrying 
value
 
Fair value
 
Level
Assets
 
 
 
 
 
 
 
 
 
 
 
Pledged treasury securities
$

 
$

 
N/A
 
$
25,670

 
$
26,501

 
1
Retained interest investments
$
10,137

 
$
13,147

 
3
 
$
9,932

 
$
13,026

 
3
Investments held by special purpose entities (Note 5)
$
208,720

 
$
209,144

 
3
 
$
209,857

 
$
209,679

 
3
Liabilities
 
 
 
 
 
 
 
 
 
 
 
Senior Notes held by special purpose entity (Note 5)
$
177,418

 
$
177,982

 
3
 
$
177,341

 
$
177,940

 
3